DE60234464D1 - Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung - Google Patents

Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung

Info

Publication number
DE60234464D1
DE60234464D1 DE60234464T DE60234464T DE60234464D1 DE 60234464 D1 DE60234464 D1 DE 60234464D1 DE 60234464 T DE60234464 T DE 60234464T DE 60234464 T DE60234464 T DE 60234464T DE 60234464 D1 DE60234464 D1 DE 60234464D1
Authority
DE
Germany
Prior art keywords
methods
compositions
nucleic acid
acid isolation
selective nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234464T
Other languages
English (en)
Inventor
Douglas A Bost
Lawrence I Greenfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Biosystems LLC
Original Assignee
Applied Biosystems LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23305266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60234464(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Biosystems LLC filed Critical Applied Biosystems LLC
Application granted granted Critical
Publication of DE60234464D1 publication Critical patent/DE60234464D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60234464T 2001-11-28 2002-11-27 Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung Expired - Lifetime DE60234464D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33402901P 2001-11-28 2001-11-28
PCT/US2002/038123 WO2003046146A2 (en) 2001-11-28 2002-11-27 Compositions and methods of selective nucleic acid isolation

Publications (1)

Publication Number Publication Date
DE60234464D1 true DE60234464D1 (de) 2009-12-31

Family

ID=23305266

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234464T Expired - Lifetime DE60234464D1 (de) 2001-11-28 2002-11-27 Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung

Country Status (7)

Country Link
US (5) US7208271B2 (de)
EP (1) EP1448799B2 (de)
JP (3) JP4106026B2 (de)
AT (1) ATE449186T1 (de)
AU (1) AU2002359522A1 (de)
DE (1) DE60234464D1 (de)
WO (1) WO2003046146A2 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078224B1 (en) * 1999-05-14 2006-07-18 Promega Corporation Cell concentration and lysate clearance using paramagnetic particles
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
JP4106026B2 (ja) 2001-11-28 2008-06-25 アプレラ コーポレイション 選択的な核酸の単離方法および組成物
JP3644641B2 (ja) * 2003-03-07 2005-05-11 株式会社日立ハイテクノロジーズ 核酸回収方法
JP4241183B2 (ja) * 2003-05-19 2009-03-18 株式会社日立ハイテクノロジーズ 核酸回収方法及び核酸回収キット
US20050009036A1 (en) * 2003-07-11 2005-01-13 Applera Corporation Methods and kits for obtaining nucleic acid from biological samples
US20050059024A1 (en) * 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
JP4871722B2 (ja) * 2003-07-25 2012-02-08 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー 固定試料からｒｎａを調製するための方法および組成物
US20050054847A1 (en) * 2003-08-01 2005-03-10 Invitrogen Corporation Compositions and methods for preparing short RNA molecules and other nucleic acids
JP2005270049A (ja) * 2004-03-26 2005-10-06 Jfe Steel Kk 核酸分子の切断方法
JP2005295869A (ja) * 2004-04-09 2005-10-27 Jfe Steel Kk 核酸分子の切断方法およびその装置
KR100714988B1 (ko) * 2005-08-09 2007-05-09 삼성전자주식회사 산화막이 표면에 형성된 실리콘 구조물 표면을 이용한ｄｎａ 정제 방법 및 정제장치
WO2007070381A2 (en) * 2005-12-09 2007-06-21 Promega Corporation Nucleic acid purification with a binding matrix
WO2007133495A1 (en) * 2006-05-10 2007-11-22 Human Genome Sciences, Inc. Mixture for decreasing protein interference
US20100216657A1 (en) * 2006-05-16 2010-08-26 Arcxis Biotechnologies, Inc. Pcr-free sample preparation and detection systems for high speed biologic analysis and identification
US8679741B2 (en) 2006-05-31 2014-03-25 Sequenom, Inc. Methods and compositions for the extraction and amplification of nucleic acid from a sample
DE102006031764B4 (de) * 2006-07-06 2009-10-01 Aj Innuscreen Gmbh Verfahren zur parallelen Isolierung doppel- und einzelsträngiger Nukleinsäuren sowie zur selektiven Entfernung doppelsträngiger Nukleinsäuren aus einem Gemisch von doppel- und einzelsträngigen Nukleinsäuren
JP4297148B2 (ja) * 2006-09-22 2009-07-15 ソニー株式会社 核酸回収装置及び核酸回収方法
GB0719022D0 (en) * 2007-09-28 2007-11-07 Mole Genetics As Isolation method
US7871764B1 (en) * 2008-03-18 2011-01-18 The United States Of America As Represented By The United States Department Of Energy Universal nucleic acids sample preparation method for cells, spores and their mixture
CA2757493C (en) 2009-04-03 2018-11-13 Sequenom, Inc. Nucleic acid preparation compositions and methods
US8222397B2 (en) * 2009-08-28 2012-07-17 Promega Corporation Methods of optimal purification of nucleic acids and kit for use in performing such methods
US8039613B2 (en) 2009-08-28 2011-10-18 Promega Corporation Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
PL2588609T3 (pl) 2010-06-29 2018-06-29 Exscale Biospecimen Solutions Ab Sposób i zestaw do sekwencyjnej izolacji nukleotydów z próbki
BR112012031267A2 (pt) 2010-07-07 2015-10-13 Diagon Kft procedimento para o isolamento específico do conteúdo de dna integral dos germes bacterianos e kit essa finalidade
JP6096774B2 (ja) 2011-08-12 2017-03-15 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング 核酸を単離するための方法
FR2994184B1 (fr) 2012-08-02 2017-12-08 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
JP6466336B2 (ja) 2012-10-24 2019-02-06 ジェンマーク ダイアグノスティクス， インコーポレイテッド 一体型多重標的分析
US20140322706A1 (en) 2012-10-24 2014-10-30 Jon Faiz Kayyem Integrated multipelx target analysis
US9453613B2 (en) 2013-03-15 2016-09-27 Genmark Diagnostics, Inc. Apparatus, devices, and methods for manipulating deformable fluid vessels
USD881409S1 (en) 2013-10-24 2020-04-14 Genmark Diagnostics, Inc. Biochip cartridge
US9498778B2 (en) 2014-11-11 2016-11-22 Genmark Diagnostics, Inc. Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system
JP2017539080A (ja) 2014-10-23 2017-12-28 コーニング インコーポレイテッド 高分子被包磁性ナノ粒子
US9598722B2 (en) 2014-11-11 2017-03-21 Genmark Diagnostics, Inc. Cartridge for performing assays in a closed sample preparation and reaction system
US10005080B2 (en) 2014-11-11 2018-06-26 Genmark Diagnostics, Inc. Instrument and cartridge for performing assays in a closed sample preparation and reaction system employing electrowetting fluid manipulation
EP3218480A1 (de) 2014-11-14 2017-09-20 Corning Incorporated Verfahren und kits zur rna-reinigung nach ivt
EP3344643A4 (de) * 2015-09-04 2019-05-01 Qiagen Sciences LLC Verfahren zur gemeinsamen isolierung von nukleinsäuren und proteinen
MX2019007444A (es) 2016-12-22 2019-08-16 Guardant Health Inc Metodos y sistemas para analisis de moleculas de acido nucleico.
PL3885445T3 (pl) 2017-04-14 2024-01-29 Guardant Health, Inc. Sposoby przyłączania adapterów do próbek kwasów nukleinowych
CN111357054B (zh) 2017-09-20 2024-07-16 夸登特健康公司 用于区分体细胞变异和种系变异的方法和系统
WO2019090156A1 (en) 2017-11-03 2019-05-09 Guardant Health, Inc. Normalizing tumor mutation burden
CA3079252A1 (en) 2017-11-03 2019-05-09 Guardant Health, Inc. Correcting for deamination-induced sequence errors
GB201718803D0 (en) * 2017-11-14 2017-12-27 Phoenix Molecular Pte Ltd Method for isolation of nucleic acids
CN108456675A (zh) * 2018-03-27 2018-08-28 爱默基因（厦门）生物科技有限公司 一种用于凝胶DNA回收的溶胶buffer、回收凝胶DNA的试剂盒及其使用方法
WO2019236478A1 (en) 2018-06-04 2019-12-12 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free nucleic acids
EP3827100A2 (de) 2018-07-23 2021-06-02 Guardant Health, Inc. Verfahren und systeme zur anpassung der tumormutationbelastung durch tumorfraktion und -deckung
SG11202101403YA (en) 2018-08-30 2021-03-30 Guardant Health Inc Methods and systems for detecting contamination between samples
WO2020047553A1 (en) 2018-08-31 2020-03-05 Guardant Health, Inc. Genetic variant detection based on merged and unmerged reads
SG11202101400UA (en) 2018-08-31 2021-03-30 Guardant Health Inc Microsatellite instability detection in cell-free dna
EP3847276A2 (de) 2018-09-04 2021-07-14 Guardant Health, Inc. Verfahren und systeme zur detektion von allelischem ungleichgewicht in zellfreien nukleinsäureproben
CN113227393A (zh) 2018-10-31 2021-08-06 夸登特健康公司 用于校准表观遗传分区测定的方法、组合物和系统
JP2022514010A (ja) 2018-12-20 2022-02-09 ガーダント ヘルス， インコーポレイテッド 核酸分子の回収率を改善するための方法、組成物、およびシステム
JP2022519045A (ja) 2019-01-31 2022-03-18 ガーダント ヘルス， インコーポレイテッド 無細胞ｄｎａを単離するための組成物および方法
EP3931831A1 (de) 2019-02-27 2022-01-05 Guardant Health, Inc. Rechnerische modellierung des funktionsverlustes basierend auf allelischer frequenz
WO2020176659A1 (en) 2019-02-27 2020-09-03 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free dna
US11939636B2 (en) 2019-05-31 2024-03-26 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
JP2022550131A (ja) 2019-09-30 2022-11-30 ガーダント ヘルス， インコーポレイテッド メチル化分配アッセイにおいて無細胞ｄｎａを解析するための組成物および方法
WO2021081423A1 (en) 2019-10-25 2021-04-29 Guardant Health, Inc. Methods for 3' overhang repair
WO2021108708A1 (en) 2019-11-26 2021-06-03 Guardant Health, Inc. Methods, compositions and systems for improving the binding of methylated polynucleotides
EP4097724A1 (de) 2020-01-31 2022-12-07 Guardant Health, Inc. Signifikanzmodellierung der abwesenheit von zielvarianten auf klonaler ebene
WO2021183821A1 (en) 2020-03-11 2021-09-16 Guardant Health, Inc. Methods for classifying genetic mutations detected in cell-free nucleic acids as tumor or non-tumor origin
EP4143338A1 (de) 2020-04-30 2023-03-08 Guardant Health, Inc. Verfahren zur sequenzbestimmung unter verwendung partitionierter nukleinsäuren
US20220025468A1 (en) 2020-05-14 2022-01-27 Guardant Health, Inc. Homologous recombination repair deficiency detection
EP4179111B1 (de) 2020-07-10 2024-04-03 Guardant Health, Inc. Verfahren zum nachweis von genomischen neuanordnungen unter verwendung zellfreier nukleinsäuren
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
WO2022026761A1 (en) 2020-07-30 2022-02-03 Guardant Health, Inc. Methods for isolating cell-free dna
WO2022046947A1 (en) 2020-08-25 2022-03-03 Guardant Health, Inc. Methods and systems for predicting an origin of a variant
EP4205122A2 (de) 2020-08-27 2023-07-05 Guardant Health, Inc. Rechnerische detektion von kopienzahlvariationen an einem locus in abwesenheit von direkter messung des locus
US20220154285A1 (en) 2020-09-30 2022-05-19 Guardant Health, Inc. Analysis of methylated dna comprising methylation-sensitive or methylation-dependent restrictions
CA3195797A1 (en) 2020-10-23 2022-04-28 Andrew Kennedy Compositions and methods for analyzing dna using partitioning and base conversion
JP2023551292A (ja) 2020-11-30 2023-12-07 ガーダント ヘルス， インコーポレイテッド メチル化されたポリヌクレオチドを富化するための組成物および方法
WO2022140629A1 (en) 2020-12-23 2022-06-30 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
EP4291679A1 (de) 2021-02-12 2023-12-20 Guardant Health, Inc. Verfahren und zusammensetzungen zum nachweis von nukleinsäurevarianten
EP4302301A1 (de) 2021-03-05 2024-01-10 Guardant Health, Inc. Verfahren und zugehörige aspekte zur analyse der molekularen reaktion
WO2022192889A1 (en) 2021-03-09 2022-09-15 Guardant Health, Inc. Detecting the presence of a tumor based on off-target polynucleotide sequencing data
EP4314329A1 (de) 2021-03-25 2024-02-07 Guardant Health, Inc. Verfahren und zusammensetzungen zur quantifizierung von immunzellen-dna
EP4348249A1 (de) 2021-05-28 2024-04-10 Guardant Health, Inc. Zusammensetzungen und verfahren zur untersuchung von zirkulierenden molekülen
JP2024523401A (ja) 2021-06-21 2024-06-28 ガーダント ヘルス， インコーポレイテッド コピー数情報に基づく組織起源分析のための方法および組成物
EP4388091A2 (de) 2021-08-20 2024-06-26 Guardant Health, Inc. Verfahren zur gleichzeitigen molekularen und probenbarcodierung
EP4409024A1 (de) 2021-09-30 2024-08-07 Guardant Health, Inc. Zusammensetzungen und verfahren zur synthese und verwendung von auf nukleinsäureneuanordnungen abzielenden sonden
EP4426858A2 (de) 2021-11-02 2024-09-11 Guardant Health, Inc. Qualitätskontrollverfahren
WO2023122623A1 (en) 2021-12-21 2023-06-29 Guardant Health, Inc. Methods and systems for combinatorial chromatin-ip sequencing
WO2023122740A1 (en) 2021-12-23 2023-06-29 Guardant Health, Inc. Compositions and methods for detection of metastasis
WO2023150633A2 (en) 2022-02-02 2023-08-10 Guardant Health, Inc. Multifunctional primers for paired sequencing reads
WO2023197004A1 (en) 2022-04-07 2023-10-12 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
WO2023220602A1 (en) 2022-05-09 2023-11-16 Guardant Health, Inc. Detecting degradation based on strand bias
WO2024006908A1 (en) 2022-06-30 2024-01-04 Guardant Health, Inc. Enrichment of aberrantly methylated dna
US20240191290A1 (en) 2022-07-21 2024-06-13 Guardant Health, Inc. Methods for detection and reduction of sample preparation-induced methylation artifacts
WO2024059840A1 (en) 2022-09-16 2024-03-21 Guardant Health, Inc. Compositions and methods for analyzing soluble proteins
WO2024073508A2 (en) 2022-09-27 2024-04-04 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
WO2024107599A1 (en) 2022-11-15 2024-05-23 Guardant Health, Inc. Method of predicting non-small cell lung cancer (nsclc) patient drug response or time until death or cancer progression from circulating tumor dna (ctdna) utilizing signals from both baseline ctdna level and longitudinal change of ctdna level over time
WO2024107941A1 (en) 2022-11-17 2024-05-23 Guardant Health, Inc. Validation of a bioinformatic model for classifying non-tumor variants in a cell-free dna liquid biopsy assay
WO2024137682A1 (en) 2022-12-21 2024-06-27 Guardant Health, Inc. Detecting homologous recombination deficiences based on methylation status of cell-free nucleic acid molecules
WO2024137880A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Methods involving methylation preserving amplification with error correction
WO2024138180A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Integrated targeted and whole genome somatic and dna methylation sequencing workflows
WO2024159053A1 (en) 2023-01-25 2024-08-02 Guardant Health, Inc. Nucleic acid methylation profiling method
WO2024186768A1 (en) 2023-03-07 2024-09-12 Guardant Health, Inc. Hybrid ssdna- and dsdna-ngs library preparation methods

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340674A (en) * 1980-05-05 1982-07-20 The Upjohn Company Cointegrate plasmids and their construction from plasmids of Escherichia and Streptomyces
US4420517A (en) 1982-05-06 1983-12-13 Becton Dickinson And Company Methods for improving uniformity of silica films on substrates
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
DE3308932A1 (de) 1983-03-12 1984-09-13 Hoechst Ag, 6230 Frankfurt Verfahren zur abtrennung von ribonukleinsaeuren aus einer loesung, die desoxyribonukleinsaeuren enthaelt
US5137816A (en) * 1983-06-22 1992-08-11 The Lubrizol Corporation Rhizobial diagnostic probes and rhizobium trifolii nifH promoters
US4648975A (en) 1983-08-17 1987-03-10 Pedro B. Macedo Process of using improved silica-based chromatographic supports containing additives
GB8519457D0 (en) * 1985-08-02 1985-09-11 Faulk Ward Page Tumour imaging agents
CA1301606C (en) 1986-05-02 1992-05-26 David H. Gillespie Chaotropic method for evaluating nucleic acids in a biological sample
US4900677A (en) * 1986-09-26 1990-02-13 E. I. Du Pont De Nemours And Company Process for rapid isolation of high molecular weight DNA
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US4923978A (en) 1987-12-28 1990-05-08 E. I. Du Pont De Nemours & Company Process for purifying nucleic acids
US5075430A (en) 1988-12-12 1991-12-24 Bio-Rad Laboratories, Inc. Process for the purification of DNA on diatomaceous earth
NL8900725A (nl) 1989-03-23 1990-10-16 Az Univ Amsterdam Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur.
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
AU5126890A (en) 1989-04-03 1990-10-04 Minnesota Mining And Manufacturing Company Metal oxide supports for nucleic acids
US5175271A (en) 1989-07-10 1992-12-29 University Of Kansas Use of silica gel for DNA extraction with organic solvents
US5106966A (en) 1989-07-10 1992-04-21 University Of Kansas Use of gel polymer for dna extraction with organic solvents
US5533888A (en) * 1990-08-21 1996-07-09 Belarde; John F. Apparatus for forming concrete barriers
AU1978692A (en) 1991-04-12 1992-11-17 Minnesota Mining And Manufacturing Company Purification of nucleic acids using metal oxide supports
CA2067711C (en) 1991-05-03 2000-08-08 Daniel Lee Woodard Solid phase extraction purification of dna
US5155018A (en) 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
US5329000A (en) 1991-10-31 1994-07-12 Becton, Dickinson And Company Purification of DNA with silicon tetrahydrazide
DE4139664A1 (de) 1991-12-02 1993-06-03 Diagen Inst Molekularbio Vorrichtung und verfahren zur isolierung und reinigung von nukleinsaeuren
US5346994A (en) 1992-01-28 1994-09-13 Piotr Chomczynski Shelf-stable product and process for isolating RNA, DNA and proteins
EP0555798B1 (de) 1992-02-13 1999-05-06 Becton, Dickinson and Company Celithydrat und Reinigung von DNS
AU669398B2 (en) 1992-11-13 1996-06-06 Becton Dickinson & Company Boron silicates aluminum silicates phosphosilicates and purification of DNA
DE4321904B4 (de) 1993-07-01 2013-05-16 Qiagen Gmbh Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
AU7375794A (en) 1993-07-28 1995-02-28 Akzo Nobel N.V. Process for isolating nucleic acid from gram positive microorganisms
AU689815B2 (en) 1993-08-30 1998-04-09 Promega Corporation Nucleic acid purification compositions and methods
US5637687A (en) 1993-08-31 1997-06-10 Wiggins; James C. Methods and compositions for isolating nucleic acids
US5438127A (en) 1993-09-27 1995-08-01 Becton Dickinson And Company DNA purification by solid phase extraction using a PCl3 modified glass fiber membrane
US5438129A (en) 1993-09-27 1995-08-01 Becton Dickinson And Company DNA purification by solid phase extraction using partially fluorinated aluminum hydroxide adsorbant
US5503816A (en) 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
DK0743950T3 (da) 1994-02-11 2002-03-25 Qiagen Gmbh Fremgangsmåde til adskillelse af dobbeltstrengede/enkeltstrengede nukleinsyre-strukturer
US5705628A (en) * 1994-09-20 1998-01-06 Whitehead Institute For Biomedical Research DNA purification and isolation using magnetic particles
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
GB9425138D0 (en) * 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US5576196A (en) 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
US5777099A (en) 1995-02-24 1998-07-07 Biotecx Laboratories, Inc. RNA separation
JP2965131B2 (ja) 1995-07-07 1999-10-18 東洋紡績株式会社 核酸結合用磁性担体およびそれを用いる核酸単離方法
US5945515A (en) 1995-07-31 1999-08-31 Chomczynski; Piotr Product and process for isolating DNA, RNA and proteins
US5804684A (en) 1995-08-24 1998-09-08 The Theobald Smith Research Institute, Inc. Method for isolating nucleic acids
US5783686A (en) 1995-09-15 1998-07-21 Beckman Instruments, Inc. Method for purifying nucleic acids from heterogenous mixtures
DE29601618U1 (de) 1996-01-31 1996-07-04 InViTek GmbH, 13125 Berlin Vorrichtung zur gleichzeitigen multiplen Isolierung
GB9602825D0 (en) 1996-02-12 1996-04-10 Therexsys Ltd Method of plasmid dna production and purification
US5973137A (en) 1996-02-13 1999-10-26 Gentra Systems, Inc. Low pH RNA isolation reagents, method, and kit
ATE284891T1 (de) 1996-02-14 2005-01-15 Biomerieux Bv Isolierung von einzelsträngigen nukleinsäuren
ZA973642B (en) * 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
DE69719409T2 (de) 1996-06-18 2004-01-15 Rikagaku Kenkyusho Verfahren zur Reinigung von DNS
DE69734263T2 (de) 1996-07-12 2006-07-13 Toyo Boseki K.K. Verfahren zur Isolierung von Ribonucleinsäuren.
US5981235A (en) 1996-07-29 1999-11-09 Promega Corporation Methods for isolating nucleic acids using alkaline protease
CA2214495C (en) 1996-09-25 2002-02-05 Daniel L. Woodard Hydrated zirconium silicate composition for purification of nucleic acids
DE69723297D1 (de) 1996-12-11 2003-08-07 Amersham Plc Little Chalfont Selektives verfahren zur lyse von zellen
JP2001524820A (ja) 1997-04-10 2001-12-04 ライフ テクノロジーズ，インコーポレイテッド Ｒｎａ単離試薬および方法
ATE347615T1 (de) * 1997-04-16 2006-12-15 Applera Corp Nukleinsäuresammlung
US6218531B1 (en) 1997-06-25 2001-04-17 Promega Corporation Method of isolating RNA
US5972613A (en) 1997-12-09 1999-10-26 The Perkin-Elmer Corporation Methods of nucleic acid isolation
DE19801730A1 (de) 1998-01-19 1999-07-22 Fraunhofer Ges Forschung Verfahren zur kombinierten Analyse von Zellinhalten, insbesondere den in biologischen Zellen enthaltenen Nukleinsäuren sowie Vorrichtung zur Durchführung des Verfahrens
CA2319665C (en) 1998-02-02 2010-06-29 Gentra Systems, Inc. Processes for isolating, amplifying and characterizing dna
JP2002502856A (ja) 1998-02-04 2002-01-29 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 核酸の単離および精製方法
WO1999051734A1 (en) 1998-04-02 1999-10-14 Kyung Il Lee Glass microfiber column and method for the preparation and purification of plasmid dna using the same
EP0969090A1 (de) 1998-05-27 2000-01-05 QIAGEN GmbH Schnelles und einfaches Verfahren zur Isolierung von zirkulären Nucleinsäuren
JP2002541839A (ja) 1999-04-21 2002-12-10 アノビス， インコーポレイテッド 植物についての磁気ｄｎａ抽出キット
US6270970B1 (en) 1999-05-14 2001-08-07 Promega Corporation Mixed-bed solid phase and its use in the isolation of nucleic acids
AU780319B2 (en) 1999-08-20 2005-03-17 Promega Corporation Simultaneous isolation and quantitation of DNA
US7001724B1 (en) † 2000-11-28 2006-02-21 Applera Corporation Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
WO2003033739A1 (en) 2001-10-12 2003-04-24 Gentra Systems, Inc. Compositions and methods for using a solid support to purify rna
JP4106026B2 (ja) * 2001-11-28 2008-06-25 アプレラ コーポレイション 選択的な核酸の単離方法および組成物

Also Published As

Publication number Publication date
AU2002359522A1 (en) 2003-06-10
JP2009039137A (ja) 2009-02-26
US20070224630A1 (en) 2007-09-27
US8507198B2 (en) 2013-08-13
EP1448799A4 (de) 2006-03-08
US7208271B2 (en) 2007-04-24
ATE449186T1 (de) 2009-12-15
EP1448799B1 (de) 2009-11-18
JP2005510233A (ja) 2005-04-21
JP2008000146A (ja) 2008-01-10
WO2003046146A3 (en) 2004-02-26
JP4106026B2 (ja) 2008-06-25
EP1448799A2 (de) 2004-08-25
US20140065626A1 (en) 2014-03-06
US7537898B2 (en) 2009-05-26
US20150086988A1 (en) 2015-03-26
WO2003046146A2 (en) 2003-06-05
US8865405B2 (en) 2014-10-21
US20030138828A1 (en) 2003-07-24
US20100021905A1 (en) 2010-01-28
AU2002359522A8 (en) 2003-06-10
EP1448799B2 (de) 2018-05-16

Similar Documents

Publication Publication Date Title
DE60234464D1 (de) Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung
DE60142254D1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
DE60230672D1 (de) Nukleinsäureanreicherung
ATE362530T1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE602004032160D1 (de) Verfahren zur Zubereitung von Getränken
AU6380001A (en) Porous ferro- or ferrimagnetic glass particles for isolating molecules
WO2003008623A3 (en) Methylation analysis using nicking agents
DE60210265D1 (de) Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren
DE50213074D1 (de) Verfahren zur Herstellung UV-vernetzter Acrylathaftklebemassen
DE60122429D1 (de) Verfahren zur Hydrierung von Kohlenwasserstoffschnitten
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
ATA11042002A (de) Verfahren zur simulation des fahrverhaltens von fahrzeugen
IL176479A0 (en) Methods and compositions for identifying rna-binding proteins
DE50201891D1 (de) Verfahren zur herstellung von 1-octen
DE60223070D1 (de) Verfahren zur herstellung von dihalogenadamantanen
DE60208738D1 (de) Verfahren zur Herstellung von Chlorfluorpolyoxyalkylenolen
DE60219193D1 (de) Verfahren zur herstellung von silylorganomercaptanen
DE602005000249D1 (de) Verfahren zur Isolierung von Bakterien aus biologischen Proben
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE50210487D1 (de) Verfahren zur Herstellung von 1-Amino-4-hydroxyanthrachinonen
DE59905922D1 (de) Verfahren zur Isolierung von Glykolen
DE60104578D1 (de) Verfahren zur Denaturierung von Allergenen
DE60329036D1 (de) Ökologisches verfahren zur herstellung von brombenzol
ATE340873T1 (de) Verfahren zur durchführung einer subtraktiven hybridisierung

Legal Events

Date Code Title Description
8363 Opposition against the patent